DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Eichelberg C, Vervenne WL, De Santis M. et al.
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.
European urology 2015;
68: 837-847
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.